Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 285,981 | 290,962 | 277,579 | 288,263 | 285,843 |
| Cost of Goods | 181,769 | 190,394 | 184,863 | 181,943 | 183,205 |
| Gross Profit | 104,212 | 100,568 | 92,716 | 106,320 | 102,638 |
| Operating Expenses | 61,241 | 59,315 | 56,485 | 53,949 | 60,592 |
| Operating Income | 43,740 | 41,647 | 37,094 | 53,314 | 42,251 |
| Interest Expense | 8,435 | 9,967 | 11,944 | 10,659 | 10,016 |
| Other Income | -159 | 974 | -609 | 150 | 427 |
| Pre-tax Income | 35,146 | 32,654 | 24,541 | 42,805 | 32,662 |
| Income Tax | 8,676 | 5,576 | 5,630 | 8,649 | -2,715 |
| Net Income Continuous | 26,470 | 27,078 | 18,911 | 34,156 | 35,377 |
| Net Income Discontinuous | 77 | 150 | -18 | -1,732 | -3,945 |
| Minority Interests | 108 | 113 | 95 | 106 | 97 |
| Net Income | $26,439 | $27,115 | $18,798 | $32,318 | $31,335 |
| EPS Basic Total Ops | 0.55 | 0.57 | 0.38 | 0.63 | 0.58 |
| EPS Basic Continuous Ops | 0.55 | 0.56 | 0.38 | 0.67 | 0.65 |
| EPS Basic Discontinuous Ops | 0.00 | -0.01 | 0.00 | -0.03 | -0.07 |
| EPS Diluted Total Ops | 0.54 | 0.57 | 0.37 | 0.63 | 0.57 |
| EPS Diluted Continuous Ops | 0.54 | 0.56 | 0.37 | 0.66 | 0.65 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.01 | 0.00 | -0.03 | -0.07 |
| EBITDA(a) | $68,087 | $67,409 | $64,640 | $79,651 | $67,846 |